India's most comprehensive portal on pharmaceutical News, …
WEB2 days ago · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
About Us - Pharmabiz.com
WEBMr. Sanjiv D Kaul, is currently the management advisor to ChrysCapital,a leading international consulting firm based in New Delhi.He is the former vice-president and head of corporate affairs, Ranbaxy Laboratories Limited and has been the key driver for Ranbaxy's aggressive internationalisation drive in markets as varied as Africa, Commonwealth of Independent States, Asia - Pacific and China ...
Health ministry bans 156 FDCs with immediate effect
WEBHealth ministry bans 156 FDCs with immediate effect: Gireesh Babu, New Delhi Thursday, August 22, 2024, 13:30 Hrs [IST] The Union ministry of health and family welfare (MoHFW) has banned 156 fixed dose combinations including common cold, fever, antibacterial and antifungal medicines with immediate effect, stating that they are irrational combinations and use of these drugs is likely to involve ...
About Pharmabiz
WEBPharmabiz.com is India's most comprehensive online news service. It provides updates on the Indian pharmaceutical industry and allied sectors like hospitals and diagnostic services. The site also gives information on education, research, government laws and policies.
Pharmexcil announces opening of visitor registration for IPHEX …
WEBAug 6, 2024 · Pharmexcil announces opening of visitor registration for IPHEX 2024 to be held from Aug 28 to 30: Shardul Nautiyal, Mumbai Tuesday, August 6, 2024, 08:00 Hrs [IST]
US FDA approves Heron Therapeutics’ prior approval supplement ...
WEBSep 26, 2024 · Heron Therapeutics, Inc., a commercial-stage biotechnology company, announced that the US Food and Drug Administration (FDA) has approved the company's Prior Approval Supplement Application for Zynrelef (bupivacaine and meloxicam) extended-release solution vial access needle (VAN). The VAN will ...
Valerio Therapeutics acquires single-domain antibody-based …
WEB4 days ago · Valerio Therapeutics S.A., a clinical-stage biotechnology company leading the way in the development of innovative DNA Decoy therapeutics, announced the acquisition of Emglev Therapeutics, a spinoff of Institut Curie, one of France’s leading cancer centres. Valour Bio has been established as a ...
Expert calls for legislation to review medical prescriptions by ...
WEB4 days ago · Since pharmacists are drug experts, a legislation is inevitable to ensure that prescriptions written by physicians should be reviewed by pharmacists in order to minimize errors and irrational use of the drugs, according to Dr. Shyam Muthaiah Panga, professor and principal at Dr. NJ Paulbudhe College ...
Sun Pharma receives exclusive worldwide rights to commercialise ...
WEB4 days ago · Sun Pharmaceutical Industries Limited, world’s leading specialty generics company, and Philogen S.p.A, an Italian-Swiss company active in the biotechnology sector, announced that they have entered into a global licensing agreement for commercializing Philogen’s specialty product, Fibromun ...
Orion Corporation’s partner Bayer submits sNDA to US FDA for …
WEBSep 28, 2024 · Finnish pharmaceutical company Orion Collaboration’s partner Bayer has announced the submission of a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) for the oral androgen receptor inhibitor (ARi) darolutamide. Bayer is seeking approval for the use of ...